Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Autor: Martinez Chanza, Nieves^1,2 (AUTHOR) Nieves.Martinez-Chanza@bordet.be, Soukane, Louisa² (AUTHOR), Barthelemy, Philippe³ (AUTHOR), Carnot, Aurélien⁴ (AUTHOR), Gil, Thierry¹ (AUTHOR), Casert, Vinciane⁵ (AUTHOR), Vanhaudenarde, Vincent⁶ (AUTHOR), Sautois, Brieuc⁷ (AUTHOR), Staudacher, Lionel⁸ (AUTHOR), Van den Brande, Jan⁹ (AUTHOR), Culine, Stephane¹⁰ (AUTHOR), Seront, Emmanuel¹¹ (AUTHOR), Gizzi, Marco¹² (AUTHOR), Albisinni, Simone² (AUTHOR), Tricard, Thibault³ (AUTHOR), Fantoni, Jean Christophe⁴ (AUTHOR), Paesmans, Marianne¹ (AUTHOR), Caparica, Rafael¹ (AUTHOR), Roumeguere, Thierry^1,2 (AUTHOR), Awada, Ahmad¹ (AUTHOR)

Publikováno v: BMC Cancer. 12/2/2021, Vol. 21 Issue 1, p1-8. 8p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.